CSIMarket
 


Fonar Corporation  (FONR)
Other Ticker:  
 
 

FONR's Net Income Growth by Quarter and Year

Fonar's Net Income results by quarter and year




FONR Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter June - 3.65 2.20 1.08
III Quarter March - 3.26 4.30 1.91
II Quarter December 2.81 5.14 3.93 4.21
I Quarter September 2.65 5.18 3.25 4.51
FY   5.46 17.23 13.68 11.71



FONR Net Income second quarter 2023 Y/Y Growth Comment
Fonar Corporation reported drop in Net Income in the second quarter 2023 by -45.29% to $ 2.81 millions, from the same quarter in 2022.
The fall in the second quarter 2023 Fonar Corporation's Net Income compares unfavorably to the Company's average Net Income increase of 14.57%.

Looking into second quarter 2023 results within Medical Equipment & Supplies industry 33 other companies have achieved higher Net Income growth. While Fonar Corporation' s Net Income meltdown of -45.29% ranks overall at the positon no. 1521 in the second quarter 2023.




FONR Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter June - 65.91 % 103.7 % -81.88 %
III Quarter March - -24.19 % 125.13 % -63.27 %
II Quarter December -45.29 % 30.79 % -6.65 % -13.37 %
I Quarter September -48.84 % 59.38 % -27.94 % 0.45 %
FY   - 25.95 % 16.82 % -42.91 %

Financial Statements
Fonar's second quarter 2023 Net Income $ 2.81 millions FONR's Income Statement
Fonar's second quarter 2022 Net Income $ 5.14 millions Quarterly FONR's Income Statement
New: More FONR's historic Net Income Growth >>


FONR Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter June - 11.96 % -48.84 % -43.46 %
III Quarter March - -36.58 % 9.41 % -54.63 %
II Quarter December 6.11 % -0.77 % 20.92 % -6.65 %
I Quarter September -27.4 % 135.45 % 200.93 % -24.33 %
FY (Year on Year)   - 25.95 % 16.82 % -42.91 %




Net Income second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #115
Overall #1521

Net Income Y/Y Growth Statistics
High Average Low
133.1 % 14.57 % -81.94 %
(Mar 31 2013)   (Jun 30 2020)
Net Income second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #115
Overall #1521
Net Income Y/Y Growth Statistics
High Average Low
133.1 % 14.57 % -81.94 %
(Mar 31 2013)   (Jun 30 2020)

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Fonar's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
202.21 % 17.03 % -60.42 %
(Sep 30 2020)  


FONR's II. Quarter Q/Q Net Income Comment
Fonar Corporation achieved in the II. Quarter 2023 below company average Net Income increase of 6.11% quarter on quarter, to $ 2.81 millions.

Albeit the II. Quarter 2023 results were beneath the regular , it has been yet good story, as the II. Quarter expension, transcends the -0.77% rise in the II. Quarter a year ago

Within Medical Equipment & Supplies industry 13 other companies have achieved higher Net Income quarter on quarter growth. While Fonar's Net Income growth quarter on quarter, overall rank is 697.


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #14
Healthcare Sector #51
Overall #697
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #14
Healthcare Sector #51
Overall #697
Net Income Q/Q Growth Statistics
High Average Low
202.21 % 17.03 % -60.42 %
(Sep 30 2020)  


FONR's II. Quarter Q/Q Net Income Comment
Fonar Corporation achieved in the II. Quarter 2023 below company average Net Income increase of 6.11% quarter on quarter, to $ 2.81 millions.

II. Quarter 2023 Net Income Q/Q growth seem to be paradoxical, although below the regular, yet it demonstrates absolute acceleration relative to the -0.77% in the same quarter a year ago Evan  Johnson, an industry veteran from Houston said.

Within Medical Equipment & Supplies industry 13 other companies have achieved higher Net Income quarter on quarter growth. While Fonar's Net Income growth quarter on quarter, overall rank is 697.


Fonar's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Net Income 12 Months Ending $ 12.38 $ 14.70 $ 17.23 $ 15.78 $ 16.81
Y / Y Net Income Growth (TTM) -26.39 % -5.78 % 26.04 % 25.67 % 65.35 %
Year on Year Net Income Growth Overall Ranking # 1361 # 1184 # 886 # 1061 # 799
Seqeuential Net Income Change (TTM) -15.81 % -14.69 % 9.24 % -6.17 % 7.75 %
Seq. Net Income Growth (TTM) Overall Ranking # 1361 # 1184 # 886 # 1061 # 799




Cumulative Net Income growth Comment
Fonar's cumulative 12 months Net Income continue to drop, but on the faster rate at -26.39% year on year, at Dec 31 2022 compare to the -5.78% decrease at Sep 30 2022. If the Fonar's fiscal year would end at Dec 31 2022, annual Net Income would be $12 millions.

Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 1184 to 1361.

Net Income TTM Q/Q Growth Statistics
High Average Low
145.98 %
9.39 %
-49.09 %
(March 31, 2016)  

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 6
Healthcare Sector # 17
Overall # 312

Net Income TTM Y/Y Growth Statistics
High Average Low
145.98 %
9.39 %
-49.09 %
(March 31, 2016)  


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 48
S&P 500 # 826
Cumulative Net Income growth Comment
Fonar's cumulative 12 months Net Income continue to drop, but on the faster rate at -26.39% year on year, at Dec 31 2022 compare to the -5.78% decrease at Sep 30 2022. If the Fonar's fiscal year would end at Dec 31 2022, annual Net Income would be $12 millions.

Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 1184 to 1361.

Net Income TTM Q/Q Growth Statistics
High Average Low
145.98 %
9.39 %
-49.09 %
(March 31, 2016)  


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 6
Healthcare Sector # 17
Overall # 312

Net Income TTM Y/Y Growth Statistics
High Average Low
145.98 %
9.39 %
-49.09 %
(March 31, 2016)  


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 48
S&P 500 # 826




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
FONR's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for FONR's Competitors
Net Income Growth for Fonar's Suppliers
Net Income Growth for FONR's Customers

You may also want to know
FONR's Annual Growth Rates FONR's Profitability Ratios FONR's Asset Turnover Ratio FONR's Dividend Growth
FONR's Roe FONR's Valuation Ratios FONR's Financial Strength Ratios FONR's Dividend Payout Ratio
FONR's Roa FONR's Inventory Turnover Ratio FONR's Growth Rates FONR's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2022
Halozyme Therapeutics Inc -1.29%$ -1.293 millions
Inmode Ltd -2.15%$ -2.153 millions
Vanda Pharmaceuticals Inc -3.07%$ -3.066 millions
Pro Dex Inc-4.97%$ -4.973 millions
Iradimed Corporation-5.63%$ -5.627 millions
Amedisys Inc -7.24%$ -7.245 millions
Lemaitre Vascular Inc -8.87%$ -8.874 millions
Acadia Healthcare Company Inc -11.71%$ -11.709 millions
Intuitive Surgical Inc -12.02%$ -12.020 millions
Eton Pharmaceuticals Inc -12.22%$ -12.223 millions
Steris Plc-13.82%$ -13.815 millions
Envista Holdings Corporation-14.34%$ -14.336 millions
Bristol myers Squibb Company-14.63%$ -14.629 millions
Amgen Inc -14.90%$ -14.903 millions
Stryker Corp-14.95%$ -14.955 millions
Exagen Inc -15.49%$ -15.489 millions
Uniqure N v -17.07%$ -17.069 millions
Qiagen N v -17.44%$ -17.438 millions
Natural Health Trends Corp -18.97%$ -18.966 millions
Merck and Co Inc -19.90%$ -19.899 millions
Chemed Corporation-21.27%$ -21.266 millions
Rapid Micro Biosystems Inc -22.31%$ -22.312 millions
Select Medical Holdings Corp-23.04%$ -23.037 millions
Baxter International Inc -23.55%$ -23.554 millions
Becton Dickinson And Company-24.93%$ -24.926 millions
Fresenius Medical Care Ag and Co Kgaa-26.64%$ -26.636 millions
Syneos Health Inc -26.90%$ -26.897 millions
Universal Health Services Inc -27.17%$ -27.165 millions
Hca Healthcare Inc -28.45%$ -28.448 millions
Iqvia Holdings Inc -28.62%$ -28.616 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CPHC's Profile

Stock Price

CPHC's Financials

Business Description

Fundamentals

Charts & Quotes

CPHC's News

Suppliers

CPHC's Competitors

Customers & Markets

Economic Indicators

CPHC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071